FDA approves Akeso’s monoclonal antibody for nasopharyngeal carcinoma
The US Food and Drug Administration (FDA) has granted approval to Akeso's differentiated programmed cell death protein 1 (PD-1) monoclonal…
The US Food and Drug Administration (FDA) has granted approval to Akeso's differentiated programmed cell death protein 1 (PD-1) monoclonal…
Swiss-based immunology company Granite Bio has secured $100m in funding for its new antibody treatments that target several autoimmune diseases.…
The European Commission (EC) has granted orphan drug designation to Dyne Therapeutics’ DYNE-251 for treating Duchenne muscular dystrophy (DMD). This…
Pharmaceutical companies in Europe are requesting the EU to adopt drug pricing strategies comparable to the US, as reported by…
Repertoire Immune Medicines has signed a partnership and licensing agreement with Roche’s Genentech, focusing on the discovery and development of…
Biogen Netherlands has received marketing authorisation from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for its Skyclarys (omaveloxolone)…
EditCo Bio has entered a strategic licensing agreement with Promega, securing access to the latter’s protein-tagging and bioluminescent identification technologies.…
ConcertAI has announced an agreement that will allow Bayer to utilise its Translational360 and AI software-as-a-service (SaaS) solutions to expedite…
TNF Pharmaceuticals and Renova Health are set to use AI and machine learning for the identification of high-risk subjects who…
Regeneron Pharmaceuticals has entered a new manufacturing and supply agreement with Fujifilm Diosynth Biotechnologies to broaden its capacity. Valued at…